Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A group of 14 large banks and other financial institutions announced that they’re going to up their support for the nuclear power industry.
The International Longshoremen’s Association is set to strike if a new contract can’t be reached with the United States Maritime Alliance.
The insurance industry needs to be careful when using AI, or else AI black boxes could render consumers uninsurable without any explanation.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
On Monday, BP announced it will put its US onshore wind power business, estimated to be worth about $2 billion, on the market.
A Labour Party official said he’d like to see legislation that heavily impacts imports of Chinese textiles — a potential problem for Shein.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
ispace plans to launch a second attempt to land a probe on the moon later this year, with a new record in mind.
Auction house Christie’s has agreed to buy Gooding and Company, a classic auto auction house, to expand its luxury offerings.
McDonald’s announced that its $5 summer meal deal, which was only supposed to last through June, will now be extended into December.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.